<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2524-177X</journal-id>
<journal-title><![CDATA[Revista médica del Hospital General de México]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. med. Hosp. Gen. Méx.]]></abbrev-journal-title>
<issn>2524-177X</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Médica del Hospital General de México A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2524-177X2020000400153</article-id>
<article-id pub-id-type="doi">10.24875/hgmx.20000096</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Gynecological cancer: Evolution of its relative frequency]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Torres-Lobatón]]></surname>
<given-names><![CDATA[Alfonso]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jiménez-Arroyo]]></surname>
<given-names><![CDATA[Elisa P.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barra-Martínez]]></surname>
<given-names><![CDATA[Rosalva]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Oliva-Posada]]></surname>
<given-names><![CDATA[Juan C.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Suárez-Juárez]]></surname>
<given-names><![CDATA[Carla A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Morgan-Ortiz]]></surname>
<given-names><![CDATA[Fred]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital General de México "Dr. Eduardo Liceaga" Oncology Service ]]></institution>
<addr-line><![CDATA[Mexico City ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Autónoma de Sinaloa Centro de Investigación en Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Culiacán ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<volume>83</volume>
<numero>4</numero>
<fpage>153</fpage>
<lpage>158</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2524-177X2020000400153&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2524-177X2020000400153&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2524-177X2020000400153&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[ Objective: The objective of the study was to show the relative frequency of gynecological cancers at an oncology unit comparing these results with two previous studies, by highlighting the increase in the number of uterine cancers.  Materials and methods: Review the number of cases of gynecological cancers at the Oncology Service of the General Hospital of Mexico from 2016 to 2017, comparing it with two previous periods, 1983-1984 and 2010-2011.  Results: We included 931 patients with gynecological cancers, 427 patients with cervical cancer (45.8%), 274 patients with uterine cancer (29.4%), and 206 patients with ovarian cancer (22.1%). When comparing these results with the previous ones, we found that the numbers of cervical cancer decreased from 86.8% to 57.8% to 45.8 % (p &lt; 0.05); uterine cancer from 4.5% to 17.9% to 29.4% (p = 0.0001); and ovarian cancer from 6.2% (p &lt; 0.05) to 19.7% (p = 0.185). The larger histological group for cervical cancer is adenocarcinomas (18.1%) and the main histology in uterine cancers is endometrial (86.8%). From this total, 71.4% patients are either overweight or obese. About 63.9% of cases were diagnosed as late-stage cancers.  Conclusions: In this series, we detected a decrease in the frequency of cervical cancers, with adenocarcinomas increasing in percentage, and a significant increase in uterine cancers associated with overweightness and obesity. Advanced stages of gynecological cancers were prevalent.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Gynecological]]></kwd>
<kwd lng="en"><![CDATA[Cancer]]></kwd>
<kwd lng="en"><![CDATA[Relative]]></kwd>
<kwd lng="en"><![CDATA[Frequency]]></kwd>
<kwd lng="en"><![CDATA[Evolution]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Islami]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Torre]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Drope]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Jemal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gobal cancer in women:cancer control priorities]]></article-title>
<source><![CDATA[Cancer Epidemiol Biomarkers Prev]]></source>
<year>2017</year>
<volume>26</volume>
<page-range>458-70</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Siegel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Naishadham]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Gemal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer statistics 2012]]></article-title>
<source><![CDATA[CA Cancer J Clin]]></source>
<year>2012</year>
<volume>62</volume>
<page-range>10-29</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<source><![CDATA[American Cancer Society. Cancer Facts and Figures]]></source>
<year>2017</year>
<page-range>21-9</page-range><publisher-loc><![CDATA[United States ]]></publisher-loc>
<publisher-name><![CDATA[American Cancer Society]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[YH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The asociation between obesity and gynecological cancer]]></article-title>
<source><![CDATA[Gynecol Min Invasive Ther]]></source>
<year>2015</year>
<volume>4</volume>
<page-range>102-5</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<collab>World Health Organization. Source Globocan. 2018, Number of New Cases Both Sexes</collab>
<source><![CDATA[International Agency for Research on Cancer]]></source>
<year>2018</year>
<page-range>1-2</page-range><publisher-loc><![CDATA[Mexico ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<collab>FIGO Committee on Gynecologic Oncology</collab>
<article-title xml:lang=""><![CDATA[Revised FIGO staging for carcinoma of the vulva, cervix and endometrium]]></article-title>
<source><![CDATA[Int J Gynecol Obstet]]></source>
<year>2009</year>
<volume>105</volume>
<page-range>103-5</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<collab>FIGO Committee on Gynecologic Oncology</collab>
<article-title xml:lang=""><![CDATA[Current FIGO staging for cancer of the vagina, fallopian tube, ovary and gestational trophoblastic neoplasia]]></article-title>
<source><![CDATA[Int J Gynaecol Obstet]]></source>
<year>2009</year>
<volume>105</volume>
<page-range>3-4</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nevadunsky]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
<name>
<surname><![CDATA[Arsdale]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Strickler]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Moadel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kaur]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Levitt]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesity and age at diagnosis of endometrial cancer]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2014</year>
<volume>124</volume>
<page-range>300-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Plata]]></surname>
<given-names><![CDATA[NP]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Román]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer ginecológico 1983-1984. Frecuencia relativa y resultados del tratamiento. Unidad de oncología]]></article-title>
<source><![CDATA[Rev Med Hosp Gen]]></source>
<year>1987</year>
<volume>50</volume>
<page-range>169-77</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Amoretti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Morgan]]></surname>
<given-names><![CDATA[OF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer ginecológico:evolución de su frecuencia relativa en una institución de alta especialidad]]></article-title>
<source><![CDATA[Gac Mex Oncol]]></source>
<year>2014</year>
<volume>13</volume>
<page-range>222-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Escamilla]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
<name>
<surname><![CDATA[De la Vara]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Lazcano]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tendencias en la mortalidad por cáncer en México de 1980 a 2011]]></article-title>
<source><![CDATA[Salud Publ Mex]]></source>
<year>2014</year>
<volume>56</volume>
<page-range>473-91</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Bustamante]]></surname>
<given-names><![CDATA[IJ]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Oliva]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Morales]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Román]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer cervicouterino. Perfil epidemiológico en 1,217 pacientes. Seguro popular]]></article-title>
<source><![CDATA[Ginecol Obstet Mex]]></source>
<year>2013</year>
<volume>81</volume>
<page-range>71-6</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hacker]]></surname>
<given-names><![CDATA[FN]]></given-names>
</name>
<name>
<surname><![CDATA[Friedlander]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer uterino]]></article-title>
<source><![CDATA[Oncología Ginecológica de Berek and Hacker]]></source>
<year>2010</year>
<edition>5th ed</edition>
<page-range>396-7</page-range><publisher-loc><![CDATA[Philadelphia, PA, USA ]]></publisher-loc>
<publisher-name><![CDATA[Lippincott Williams &amp; Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[NI]]></given-names>
</name>
<name>
<surname><![CDATA[Cuevas]]></surname>
<given-names><![CDATA[NL]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Shama]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[González de]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología de la obesidad y sus principales comorbilidades en México]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Dommarco]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<source><![CDATA[La Obesidad en México. Estado de la Política Pública y Recomendaciones Para su Prevención y Control]]></source>
<year>2018</year>
<page-range>31-8</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Instituto Nacional de Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pocrnich]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ramalingam]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Euscher]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Malpica]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuroendocrine carcinoma of the endometrium;a clincopathologic study of 25 cases]]></article-title>
<source><![CDATA[Am J Surg Pathol]]></source>
<year>2016</year>
<volume>40</volume>
<page-range>577-86</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fujiwara]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Monk]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Devouassoux-Shisheboran]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adenocaricnoma of the uterine cervix:Why is it different?]]></article-title>
<source><![CDATA[Curr Oncol Rep]]></source>
<year>2014</year>
<volume>16</volume>
<page-range>416-22</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[BereK]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Friedlander]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hacker]]></surname>
<given-names><![CDATA[NF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer epitelial de ovario, de trompas de Falopio y peritoneal]]></article-title>
<source><![CDATA[Oncología Ginecológica de Berek and Hacker]]></source>
<year>2010</year>
<edition>5th ed</edition>
<page-range>455-6</page-range><publisher-loc><![CDATA[Philadelphia, PA, USA ]]></publisher-loc>
<publisher-name><![CDATA[Lippincott Williams &amp; Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Minig]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Barceló]]></surname>
<given-names><![CDATA[BI]]></given-names>
</name>
<name>
<surname><![CDATA[Zorrero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Velasco]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dignóstico, estadiaje y diagnóstico precoz del cáncer epitelial de ovario]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Velasco]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
</person-group>
<source><![CDATA[Cáncer de Ovario]]></source>
<year>2017</year>
<page-range>14-21</page-range><publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Permanyer]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
